{
    "type": "ETP",
    "ucits": false,
    "leverage": true,
    "derivatives": true,
    "swaps": true,
    "inverse": true,
    "replication_method": "synthetic",
    "complex_factors": [
        "Leverage",
        "Synthetic replication via swaps",
        "Counterparty risk",
        "Collateralized swap exposure",
        "Daily leverage reset and compounding effects",
        "Opaque payoff structure",
        "High risk rating (7/7)",
        "Use of total return swaps with Natixis as swap provider"
    ],
    "classification": "complex",
    "supporting_data": "The product is a 3x short leveraged ETP on Glencore plc, using a swap with Natixis as the swap provider, collateralized daily. It employs synthetic replication through total return swaps to achieve -3 times the daily performance of the underlying asset. The leverage is significant (3x), with daily reset causing compounding effects that make returns over longer periods deviate from simple multiples of the underlying. The structure involves counterparty risk (swap provider default risk) and collateral risk, which are complex concepts for retail investors. The product is explicitly described as high risk (risk class 7/7), with potential for total loss of capital. The product is not UCITS compliant but an ETP. According to MiFID II rules and ESMA guidance, such synthetic, leveraged, swap-based products with embedded derivatives and complex payoff profiles are classified as complex. The use of derivatives is integral to the investment objective, not merely for efficient portfolio management. The productu2019s payoff and risks are not straightforward for a retail investor with basic knowledge to understand. Therefore, it fails the non-complex criteria under Article 57 of the MiFID II Delegated Regulation and related ESMA guidelines. This classification aligns with the regulatory framework that all leveraged, synthetic replication ETFs or ETPs with embedded swaps and complex payoff structures are complex financial instruments requiring appropriateness assessments under MiFID II."
}